X4 Pharmaceuticals Grants 160,000 Stock Options at $4.31 Exercise Price
XFOR•On May 29, 2026 X4 Pharmaceuticals granted inducement stock options to new employees under its 2019 Inducement Equity Incentive Plan totaling 160,000 shares. Each option has a ten-year term, $4.31 exercise price and vests over four years with 25% after one year and monthly thereafter.
1. Inducement Grants Issued
On May 29, 2026 X4 Pharmaceuticals issued inducement awards to new employees under Nasdaq Listing Rule 5635(c)(4) via its 2019 Inducement Equity Incentive Plan, granting options to purchase 160,000 shares of common stock.
2. Option Terms
Each option carries a ten-year term and an exercise price of $4.31 per share, which matched the closing price of X4’s common stock on the grant date.
3. Vesting Schedule
Options vest over a four-year period with 25% of the shares vesting after 12 months and the remaining 75% vesting monthly over the following 36 months, contingent on continued employment.
4. Governance and Approval
The inducement awards were approved by the Compensation Committee of X4 Pharmaceuticals’ Board of Directors in compliance with the requirements of the 2019 Inducement Plan.
